Products for Research Use Only
RegisterLogin

DDL-218

CAT: 0804-HY-176434-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-176434-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
DDL-218 is an orally active and potent SirT1 inhibitor. DDL-218 enhances SirT1 in ApoE4-expressing neurons and a murine AD model. DDL-218 can be used in the study of Alzheimer's disease[1].
CAS Number
2767324-34-3
UNSPSC
12352005
Target
Sirtuin
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Field of Research
Neurological Disease
Purity
99.49
Smiles
N[C@@H](C)C(OC(C)(C)CC1=CC=NC=C1)=O
Molecular Formula
C12H18N2O2
Molecular Weight
222.28
References & Citations
[1]Campagna J, et al. Discovery of an ApoE4-targeted small-molecule SirT1 enhancer for the treatment of Alzheimer's disease. Sci Rep. 2025 Apr 23;15 (1) :14028.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-176438-01DDL-357
HY-19071BK-218
HY-163042-01HSGN-218
HY-19262TAK-218
HY-111449-01BAY-218
HY-106766DHP-218
HY-163631Antibacterial agent 218
HY-158391Anticancer agent 218
HY-D1035-01Direct blue 218
HY-W999620CRBN ligand-218

Alternative Products

CatalogName
T207253-01DDL-218
GTR17966972Ddl Antibody
T210753-01DDL-357
GTR18989255-01Ddl Protein
B8464-5BAY-218
T88659-01TAK-218
T73328L-01P 218
32-6781-10GST, 218 a.a.
sc-52834Triiodothyronine (218)
MBS5780114BK 218

Popular Products